CYTOXAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cytoxan, and when can generic versions of Cytoxan launch?
Cytoxan is a drug marketed by Baxter Hlthcare and is included in two NDAs.
The generic ingredient in CYTOXAN is cyclophosphamide. There are nineteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cytoxan
A generic version of CYTOXAN was approved as cyclophosphamide by BAXTER HLTHCARE on May 21st, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CYTOXAN?
- What are the global sales for CYTOXAN?
- What is Average Wholesale Price for CYTOXAN?
Summary for CYTOXAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Clinical Trials: | 1,025 |
| Patent Applications: | 6,189 |
| DailyMed Link: | CYTOXAN at DailyMed |
Recent Clinical Trials for CYTOXAN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Incyte Corporation | PHASE2 |
| Fred Hutchinson Cancer Center | PHASE2 |
| Medical University of South Carolina | PHASE2 |
US Patents and Regulatory Information for CYTOXAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | CYTOXAN | cyclophosphamide | INJECTABLE;INJECTION | 012142-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Baxter Hlthcare | CYTOXAN (LYOPHILIZED) | cyclophosphamide | INJECTABLE;INJECTION | 012142-005 | Aug 30, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Baxter Hlthcare | CYTOXAN | cyclophosphamide | TABLET;ORAL | 012141-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
